Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Family Physician
MBBS (pak) , FCPS (pak) , MRCGP (UK), MRCS (UK), CCT (UK) , PG CERT, Diabetes (UK), MCFPC (Canada)
Family Physician
MBBS (pak) , FCPS (pak) , MRCGP (UK), MRCS (UK), CCT (UK) , PG CERT, Diabetes (UK), MCFPC (Canada)
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Gastroenterologist
MBBS, MACG (USA), MD (Gastroenterology)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Diabetologist
M.B.B.S, F.C.P.S (Medicine), M.R.C.P. (Medicine), OJT (England)
Internal Medicine Specialist
M.B.B.S., Certificate in Diabetology (USA), Diploma in Gastroenterology and Hepatology (RCP-UK)
Internal Medicine Specialist
M.B.B.S., Certificate in Diabetology (USA), Diploma in Gastroenterology and Hepatology (RCP-UK)
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures